Zumantu,
I appreciate the research and DD you complete to identify potential therapeutic applications for Vascepa, EPA, Omega 3's. The information you share is really great!
Based on what you have learned, I have a couple of questions:
1) Are the potential therapeutic opportunities you have identified aligned primarily with; a) EPA alone(therefore exclusively aligned with Vascepa), or b)a mixture of EPA and DHA (therefore inclusive of Lovaza, or c) Omega 3 Fatty Acids in general.
2) Based on what you have identified, do you feel EPA is the true beneficial component? Do you feel DHA has therapeutic value, or does it dilute the EPA benefits, or even counteract them.
My questions are obviously focused on determining if Amarin can differentiate Vascepa from other EPA/ DHA products for the potential opportunities you have found.
I appreciate your thoughts and insight.
Chuckles
Market Data 
Markets 
